Subbu Nambi
Stock Analyst at Guggenheim
(2.07)
# 2,818
Out of 4,832 analysts
38
Total ratings
37.93%
Success rate
-1.95%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Buy | $122 → $114 | $78.21 | +45.76% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $29.52 | +69.38% | 2 | May 6, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $187.82 | +33.11% | 1 | Apr 23, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $6.50 | +53.85% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $54.87 | +9.35% | 2 | Apr 11, 2025 | |
| NEOG Neogen | Maintains: Buy | $15 → $13 | $6.38 | +103.76% | 2 | Apr 10, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $3.84 | - | 2 | Apr 9, 2025 | |
| VCYT Veracyte | Maintains: Buy | $45 → $37 | $28.49 | +29.87% | 3 | Apr 9, 2025 | |
| TEM Tempus AI | Reiterates: Buy | n/a | $64.78 | - | 2 | Feb 25, 2025 | |
| BRKR Bruker | Reiterates: Buy | n/a | $36.85 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $40.72 | +37.52% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $151.34 | +32.15% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $32.89 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.06 | +96.08% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.88 | +580.58% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.12 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $128.04 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $16.32 | +53.19% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.10 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.95 | - | 1 | Dec 14, 2023 |
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $78.21
Upside: +45.76%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $29.52
Upside: +69.38%
Danaher
Apr 23, 2025
Reiterates: Buy
Price Target: $250
Current: $187.82
Upside: +33.11%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $6.50
Upside: +53.85%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $54.87
Upside: +9.35%
Neogen
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $6.38
Upside: +103.76%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.84
Upside: -
Veracyte
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $28.49
Upside: +29.87%
Tempus AI
Feb 25, 2025
Reiterates: Buy
Price Target: n/a
Current: $64.78
Upside: -
Bruker
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $36.85
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $40.72
Upside: +37.52%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $151.34
Upside: +32.15%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $32.89
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.06
Upside: +96.08%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.88
Upside: +580.58%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.12
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $128.04
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $16.32
Upside: +53.19%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.10
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $0.95
Upside: -